194 related articles for article (PubMed ID: 29581480)
1. Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation.
Duncan CN; Brazauskas R; Huang J; Shaw BE; Majhail NS; Savani BN; Flowers MED; Battiwalla M; Beebe K; Dietz AC; Dvorak CC; Giller R; Jacobsohn DA; Kletzel M; Martin PL; Nemecek ER; Nuechterlein B; Talano JA; Pulsipher MA; Baker KS
Bone Marrow Transplant; 2018 Oct; 53(10):1278-1287. PubMed ID: 29581480
[TBL] [Abstract][Full Text] [Related]
2. Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age.
Vrooman LM; Millard HR; Brazauskas R; Majhail NS; Battiwalla M; Flowers ME; Savani BN; Akpek G; Aljurf M; Bajwa R; Baker KS; Beitinjaneh A; Bitan M; Buchbinder D; Chow E; Dandoy C; Dietz AC; Diller L; Gale RP; Hashmi SK; Hayashi RJ; Hematti P; Kamble RT; Kasow KA; Kletzel M; Lazarus HM; Malone AK; Marks DI; O'Brien TA; Olsson RF; Ringden O; Seo S; Steinberg A; Yu LC; Warwick A; Shaw B; Duncan C
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1327-1334. PubMed ID: 28461213
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Subsequent Central Nervous System Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant: A Study from the Center for International Blood and Marrow Transplant Research (CIBMTR).
Gabriel M; Shaw BE; Brazauskas R; Chen M; Margolis DA; Sengelov H; Dahlberg A; Ahmed IA; Delgado D; Lazarus HM; Gibson B; Myers KC; Kamble RT; Abdel-Mageed A; Li CK; Flowers MED; Battiwalla M; Savani BN; Majhail N; Shaw PJ
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1320-1326. PubMed ID: 28411175
[TBL] [Abstract][Full Text] [Related]
4. Adverse health events and late mortality after pediatric allogeneic hematopoietic SCT-two decades of longitudinal follow-up.
Wilhelmsson M; Vatanen A; Borgström B; Gustafsson B; Taskinen M; Saarinen-Pihkala UM; Winiarski J; Jahnukainen K
Bone Marrow Transplant; 2015 Jun; 50(6):850-7. PubMed ID: 25798676
[TBL] [Abstract][Full Text] [Related]
5. ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation.
Logan AC; Wang Z; Alimoghaddam K; Wong RM; Lai T; Negrin RS; Grumet C; Logan BR; Zhang MJ; Spellman SR; Lee SJ; Miklos DB;
Biol Blood Marrow Transplant; 2015 Apr; 21(4):746-54. PubMed ID: 25572032
[TBL] [Abstract][Full Text] [Related]
6. Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Omer AK; Weisdorf DJ; Lazaryan A; Shanley R; Blazar BR; MacMillan ML; Brunstein C; Bejanyan N; Arora M
Biol Blood Marrow Transplant; 2016 May; 22(5):879-83. PubMed ID: 26743342
[TBL] [Abstract][Full Text] [Related]
7. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
[TBL] [Abstract][Full Text] [Related]
8. Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation.
Leger KJ; Baker KS; Cushing-Haugen KL; Flowers MED; Leisenring WM; Martin PJ; Mendoza JA; Reding KW; Syrjala KL; Lee SJ; Chow EJ
Cancer; 2018 Apr; 124(7):1507-1515. PubMed ID: 29315507
[TBL] [Abstract][Full Text] [Related]
9. Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico.
Orti G; Sanz J; Bermudez A; Caballero D; Martinez C; Sierra J; Cabrera Marin JR; Espigado I; Solano C; Ferrà C; García-Noblejas A; Jimenez S; Sampol A; Yañez L; García-Gutiérrez V; Pascual MJ; Jurado M; Moraleda JM; Valcarcel D; Sanz MA; Carreras E; Duarte RF
Biol Blood Marrow Transplant; 2016 Mar; 22(3):584-8. PubMed ID: 26631751
[TBL] [Abstract][Full Text] [Related]
10. Day +100 Platelet Count Predicts Survival After Allogeneic Hematopoietic Stem-Cell Transplantation in Children With Hematologic Malignancies.
Moneib H; Hafez H; Abdalla A; Hassanain O; Lehmann L; Haddad AE
Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):e221-e227. PubMed ID: 30846344
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in Childhood.
Holmqvist AS; Chen Y; Wu J; Battles K; Bhatia R; Francisco L; Hageman L; Kung M; Ness E; Parman M; Salzman D; Wadhwa A; Winther JF; Rosenthal J; Forman SJ; Weisdorf DJ; Armenian SH; Arora M; Bhatia S
JAMA Oncol; 2018 Dec; 4(12):e182453. PubMed ID: 30054602
[TBL] [Abstract][Full Text] [Related]
12. Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy.
Lee CJ; Wang T; Chen K; Arora M; Brazauskas R; Spellman SR; Kitko C; MacMillan ML; Pidala JA; Auletta JJ; Badawy SM; Bhatt N; Bhatt VR; Cahn JY; DeFilipp Z; Diaz MA; Farhadfar N; Gadalla S; Gale RP; Hashem H; Hashmi S; Hematti P; Hong S; Hossain NM; Inamoto Y; Lekakis LJ; Modi D; Patel S; Sharma A; Solomon S; Couriel DR
Transplant Cell Ther; 2022 Oct; 28(10):712.e1-712.e8. PubMed ID: 35863740
[TBL] [Abstract][Full Text] [Related]
13. Late cardiovascular complications after hematopoietic cell transplantation.
Chow EJ; Wong K; Lee SJ; Cushing-Haugen KL; Flowers ME; Friedman DL; Leisenring WM; Martin PJ; Mueller BA; Baker KS
Biol Blood Marrow Transplant; 2014 Jun; 20(6):794-800. PubMed ID: 24565992
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular Risk Factors in Survivors of Childhood Hematopoietic Cell Transplantation Treated with Total Body Irradiation: A Longitudinal Analysis.
Friedman DN; Hilden P; Moskowitz CS; Suzuki M; Boulad F; Kernan NA; Wolden SL; Oeffinger KC; Sklar CA
Biol Blood Marrow Transplant; 2017 Mar; 23(3):475-482. PubMed ID: 28040534
[TBL] [Abstract][Full Text] [Related]
15. Long term survival among patients who are disease free at 1-year post allogeneic hematopoietic cell transplantation: a single center analysis of 389 consecutive patients.
Solh MM; Bashey A; Solomon SR; Morris LE; Zhang X; Brown S; Holland HK
Bone Marrow Transplant; 2018 May; 53(5):576-583. PubMed ID: 29335633
[TBL] [Abstract][Full Text] [Related]
16. Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor.
Rovó A; Daikeler T; Halter J; Heim D; Tsakiris DA; Stern M; Waltimo T; Studt JD; Tyndall A; Gratwohl A; Tichelli A
Haematologica; 2011 Jan; 96(1):150-5. PubMed ID: 20851864
[TBL] [Abstract][Full Text] [Related]
17. Impact of Obesity on Clinical Outcomes of Elderly Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancies.
Voshtina E; Szabo A; Hamadani M; Fenske TS; D'Souza A; Chhabra S; Saber W; Drobyski WR; Hari P; Shah NN
Biol Blood Marrow Transplant; 2019 Jan; 25(1):e33-e38. PubMed ID: 30244105
[TBL] [Abstract][Full Text] [Related]
18. Central Nervous System Complications after Allogeneic Hematopoietic Stem Cell Transplantation in Children.
Ke P; Bao X; Zhou J; Zhu Q; Zhuang J; Hu X; Liu Y; Wu D; Xue S; Zhang X; Ma X
Acta Haematol; 2019; 142(4):217-223. PubMed ID: 31597154
[TBL] [Abstract][Full Text] [Related]
19. Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes.
Yakushijin K; Atsuta Y; Doki N; Yokota A; Kanamori H; Miyamoto T; Ohwada C; Miyamura K; Nawa Y; Kurokawa M; Mizuno I; Mori T; Onizuka M; Taguchi J; Ichinohe T; Yabe H; Morishima Y; Kato K; Suzuki R; Fukuda T
Bone Marrow Transplant; 2016 Mar; 51(3):403-9. PubMed ID: 26595082
[TBL] [Abstract][Full Text] [Related]
20. Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome.
Kim HT; Armand P; Frederick D; Andler E; Cutler C; Koreth J; Alyea EP; Antin JH; Soiffer RJ; Ritz J; Ho VT
Biol Blood Marrow Transplant; 2015 May; 21(5):873-80. PubMed ID: 25623931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
